大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/12 | 4,775 | 4,780 | 4,692 | 4,740 | -32 | -0.7% | 1,124,400 |
2020/08/11 | 4,652 | 4,822 | 4,631 | 4,772 | +173 | +3.8% | 1,460,100 |
2020/08/07 | 4,569 | 4,624 | 4,446 | 4,599 | +90 | +2% | 1,266,400 |
2020/08/06 | 4,518 | 4,528 | 4,491 | 4,509 | -30 | -0.7% | 548,500 |
2020/08/05 | 4,570 | 4,571 | 4,490 | 4,539 | -8 | -0.2% | 471,600 |
2020/08/04 | 4,478 | 4,568 | 4,478 | 4,547 | +91 | +2% | 594,100 |
2020/08/03 | 4,408 | 4,460 | 4,380 | 4,456 | +86 | +2% | 846,000 |
2020/07/31 | 4,478 | 4,512 | 4,369 | 4,370 | -107 | -2.4% | 1,125,400 |
2020/07/30 | 4,517 | 4,536 | 4,472 | 4,477 | -37 | -0.8% | 3,996,700 |
2020/07/29 | 4,510 | 4,530 | 4,474 | 4,514 | -7 | -0.2% | 918,100 |
2020/07/28 | 4,538 | 4,577 | 4,510 | 4,521 | +13 | +0.3% | 959,000 |
2020/07/27 | 4,450 | 4,529 | 4,441 | 4,508 | +1 | ±0% | 1,137,300 |
2020/07/22 | 4,517 | 4,528 | 4,490 | 4,507 | -27 | -0.6% | 848,700 |
2020/07/21 | 4,557 | 4,587 | 4,534 | 4,534 | -49 | -1.1% | 851,200 |
2020/07/20 | 4,531 | 4,590 | 4,513 | 4,583 | +50 | +1.1% | 602,400 |
2020/07/17 | 4,540 | 4,553 | 4,505 | 4,533 | +34 | +0.8% | 596,400 |
2020/07/16 | 4,521 | 4,541 | 4,456 | 4,499 | -92 | -2% | 1,323,300 |
2020/07/15 | 4,563 | 4,617 | 4,544 | 4,591 | +41 | +0.9% | 774,500 |
2020/07/14 | 4,556 | 4,620 | 4,540 | 4,550 | -41 | -0.9% | 824,500 |
2020/07/13 | 4,550 | 4,597 | 4,495 | 4,591 | +145 | +3.3% | 837,000 |
2020/07/10 | 4,515 | 4,543 | 4,440 | 4,446 | -54 | -1.2% | 1,249,300 |
2020/07/09 | 4,509 | 4,536 | 4,460 | 4,500 | -79 | -1.7% | 1,311,800 |
2020/07/08 | 4,533 | 4,634 | 4,516 | 4,579 | +72 | +1.6% | 1,804,200 |
2020/07/07 | 4,582 | 4,587 | 4,482 | 4,507 | -126 | -2.7% | 1,560,400 |
2020/07/06 | 4,582 | 4,662 | 4,580 | 4,633 | +36 | +0.8% | 998,600 |
2020/07/03 | 4,611 | 4,622 | 4,553 | 4,597 | +8 | +0.2% | 927,900 |
2020/07/02 | 4,604 | 4,647 | 4,571 | 4,589 | +14 | +0.3% | 764,200 |
2020/07/01 | 4,719 | 4,719 | 4,557 | 4,575 | -124 | -2.6% | 1,098,800 |
2020/06/30 | 4,780 | 4,780 | 4,686 | 4,699 | +24 | +0.5% | 1,113,100 |
2020/06/29 | 4,740 | 4,742 | 4,619 | 4,675 | -213 | -4.4% | 1,321,000 |
2020/06/26 | 4,891 | 4,934 | 4,848 | 4,888 | +40 | +0.8% | 872,100 |
2020/06/25 | 4,870 | 4,899 | 4,802 | 4,848 | -66 | -1.3% | 1,099,400 |
2020/06/24 | 4,945 | 4,957 | 4,892 | 4,914 | -33 | -0.7% | 1,148,500 |
2020/06/23 | 4,909 | 4,978 | 4,842 | 4,947 | +60 | +1.2% | 866,000 |
2020/06/22 | 4,830 | 4,925 | 4,817 | 4,887 | +98 | +2% | 694,400 |
2020/06/19 | 4,824 | 4,840 | 4,773 | 4,789 | -43 | -0.9% | 1,700,400 |
2020/06/18 | 4,871 | 4,889 | 4,802 | 4,832 | -20 | -0.4% | 493,700 |
2020/06/17 | 4,943 | 4,945 | 4,826 | 4,852 | -41 | -0.8% | 750,300 |
2020/06/16 | 4,771 | 4,914 | 4,744 | 4,893 | +181 | +3.8% | 1,079,900 |
2020/06/15 | 4,760 | 4,844 | 4,710 | 4,712 | -95 | -2% | 629,500 |
2020/06/12 | 4,840 | 4,843 | 4,683 | 4,807 | +3 | +0.1% | 1,536,300 |
2020/06/11 | 4,860 | 4,911 | 4,800 | 4,804 | -165 | -3.3% | 1,444,400 |
2020/06/10 | 4,901 | 4,969 | 4,889 | 4,969 | +60 | +1.2% | 1,174,000 |
2020/06/09 | 4,921 | 4,924 | 4,850 | 4,909 | -22 | -0.4% | 906,500 |
2020/06/08 | 4,910 | 4,939 | 4,842 | 4,931 | +40 | +0.8% | 1,142,500 |
2020/06/05 | 4,851 | 4,891 | 4,824 | 4,891 | -7 | -0.1% | 1,004,500 |
2020/06/04 | 4,893 | 4,910 | 4,824 | 4,898 | +37 | +0.8% | 894,400 |
2020/06/03 | 4,893 | 4,915 | 4,815 | 4,861 | +16 | +0.3% | 906,200 |
2020/06/02 | 4,770 | 4,860 | 4,752 | 4,845 | +106 | +2.2% | 828,800 |
2020/06/01 | 4,750 | 4,791 | 4,682 | 4,739 | -125 | -2.6% | 1,318,700 |
1051~
1100
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム